|Bid||0.00 x 800|
|Ask||165.88 x 800|
|Day's range||152.51 - 162.77|
|52-week range||152.51 - 343.96|
|Beta (5Y monthly)||0.85|
|PE ratio (TTM)||58.21|
|Earnings date||01 Jun 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||257.78|
BD's (BDX) new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States to aid lab technicians in prioritizing higher value work.
Cooper Companies (COO) continues to benefit from strength in its business segments.
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.